Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Janssen-Cilag International NV

Medicines register · Ireland

Janssen-Cilag International NV — licensed medicines

99 medicines held by Janssen-Cilag International NV on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Akeega 100mg/500 mg Film-coated tablet EU/1/23/1722/002

Niraparib Tosilate Monohydrate, Abiraterone acetate

Janssen-Cilag International NV

—

Akeega 50 mg/500 mg Film-coated tablet EU/1/23/1722/001

Niraparib Tosilate Monohydrate, Abiraterone acetate

Janssen-Cilag International NV

—

Balversa 3 mg Film-coated tablet EU/1/24/1841/001-004

Erdafitinib

Janssen-Cilag International NV

—

Balversa 4 mg Film-coated tablet EU/1/24/1841/005-009

Erdafitinib

Janssen-Cilag International NV

—

Balversa 5 mg Film-coated tablet EU/1/24/1841/010-011

Erdafitinib

Janssen-Cilag International NV

—

BYANNLI 1 000 mg prolonged-release suspension for injection in pre-filled syringe EU/1/20/1453/008

Paliperidone palmitate

Janssen-Cilag International NV

—

BYANNLI 700 mg prolonged-release suspension for injection in pre-filled syringe EU/1/20/1453/007

Paliperidone palmitate

Janssen-Cilag International NV

—

Dacogen 50 mg powder for concentrate for solution for infusion EU/1/12/792/001

Decitabine

Janssen-Cilag International NV

—

DARZALEX 1800 mg solution for injection EU/1/16/1101/004

Daratumumab

Janssen-Cilag International NV

—

DARZALEX 20 mg/mL concentrate for solution for infusion EU/1/16/1101/001-003

Daratumumab

Janssen-Cilag International NV

—

EDURANT 2.5 mg film-coated tablets EU/1/11/736/002

Rilpivirine

Janssen-Cilag International NV

—

EDURANT 25 mg film-coated tablets EU/1/11/736/001

Rilpivirine hydrochloride

Janssen-Cilag International NV

—

Erleada 240 mg film-coated tablets EU/1/18/1342/004-006

APALUTAMIDE

Janssen-Cilag International NV

—

Erleada 60 mg film-coated tablets EU/1/18/1342/001-003

APALUTAMIDE

Janssen-Cilag International NV

—

Imaavy 185 mg/mL concentrate for solution for infusion EU/1/25/1989/001-002

Nipocalimab

Janssen-Cilag International NV

—

IMBRUVICA 140 mg film-coated tablets EU/1/14/945/007-008

Ibrutinib

Janssen-Cilag International NV

—

IMBRUVICA 140 mg hard capsules EU/1/14/945/001-002

Ibrutinib

Janssen-Cilag International NV

—

IMBRUVICA 280 mg film-coated tablets EU/1/14/945/009-010

Ibrutinib

Janssen-Cilag International NV

—

IMBRUVICA 420 mg film-coated tablets EU/1/14/945/005

Ibrutinib

Janssen-Cilag International NV

—

IMBRUVICA 560 mg film-coated tablets EU/1/14/945/006

Ibrutinib

Janssen-Cilag International NV

—

Intelence 100 mg tablets EU/1/08/468/1

Etravirine

Janssen-Cilag International NV

—

Intelence 200 mg tablets EU/1/08/468/002

Etravirine

Janssen-Cilag International NV

—

Intelence 25 mg tablets EU/1/08/468/003

Etravirine

Janssen-Cilag International NV

—

INVEGA 12 mg prolonged-release tablets EU/1/07/395/16-20

Paliperidone

Janssen-Cilag International NV

—

INVEGA 3 mg prolonged-release tablets EU/1/07/395/1-5

Paliperidone

Janssen-Cilag International NV

—

INVEGA 6 mg prolonged-release tablets EU/1/07/395/6-10

Paliperidone

Janssen-Cilag International NV

—

INVEGA 9 mg prolonged-release tablets EU/1/07/395/11-15

Paliperidone

Janssen-Cilag International NV

—

Invokana 100 mg film-coated tablets EU/1/13/884/001-004

Canagliflozin

Janssen-Cilag International NV

—

Invokana 300 mg film-coated tablets EU/1/13/884/005-008

Canagliflozin

Janssen-Cilag International NV

—

Lazcluze 240 mg film-coated tablets EU/1/24/1886/004-006

Lazertinib

Janssen-Cilag International NV

—

Lazcluze 80 mg film-coated tablets EU/1/24/1886/001-003

Lazertinib

Janssen-Cilag International NV

—

Prezista EU/1/06/380/003

Darunavir

Janssen-Cilag International NV

—

Prezista EU/1/06/380/006

Janssen-Cilag International NV

—

Prezista 150 mg film-coated tablets EU/1/06/380/004

Darunavir (as ethanolate)

Janssen-Cilag International NV

—

PREZISTA 600 mg film-coated tablets EU/1/06/380/002

Darunavir (as ethanolate)

Janssen-Cilag International NV

—

Prezista 75 mg film-coated tablets EU/1/06/380/005

Darunavir (as ethanolate)

Janssen-Cilag International NV

—

Prezista 800 mg film-coated tablet EU/1/06/380/007

Darunavir (as ethanolate)

Janssen-Cilag International NV

—

REKAMBYS 600 mg prolonged-release suspension for injection EU/1/20/1482/001

Rilpivirine

Janssen-Cilag International NV

—

REKAMBYS 900 mg prolonged-release suspension for injection EU/1/20/1482/002

Rilpivirine

Janssen-Cilag International NV

—

Remicade 100 mg Powder for concentrate for solution for infusion EU/1/99/116/001-5

Infliximab

Janssen-Cilag International NV

—

REZOLSTA 675 mg/150 mg film-coated tablets EU/1/14/967/002

Darunavir ethanolate, Cobicistat

Janssen-Cilag International NV

—

REZOLSTA 800 mg/150 mg film-coated tablets EU/1/14/967/001

Darunavir, Cobicistat

Janssen-Cilag International NV

—

Rybrevant 1 600 mg solution for injection EU/1/21/1594/002

Amivantamab

Janssen-Cilag International NV

—

Rybrevant 2240 mg solution for injection EU/1/21/1594/003

Amivantamab

Janssen-Cilag International NV

—

Rybrevant 350 mg concentrate for solution for infusion EU/1/21/1594/001

Amivantamab

Janssen-Cilag International NV

—

Simponi 100 mg solution for injection in pre-filled pen EU/1/09/546/005-008

Golimumab

Janssen-Cilag International NV

—

Simponi 45 mg/0.45 mL solution for injection in pre-filled pen. EU/1/09/546/009

Golimumab

Janssen-Cilag International NV

—

Simponi 50 mg solution for injection in pre-filled pen EU/1/09/546/1-4

Golimumab

Janssen-Cilag International NV

—

SIRTURO 100 mg tablets EU/1/13/901/001

Bedaquiline fumarate

Janssen-Cilag International NV

—

SIRTURO 20 mg tablets EU/1/13/901/003

Bedaquiline fumarate

Janssen-Cilag International NV

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/company/janssen-cilag-international-nv

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.